期刊文献+

HPLC法测定注射用丹参酮Ⅱ_A磺酸钠含量及其有关物质 被引量:9

Determination of tanshinone Ⅱ_A sulfonate and related substances in sulfotanshinone sodium injection by HPLC
下载PDF
导出
摘要 目的:建立注射用丹参酮ⅡA磺酸钠中丹参酮ⅡA磺酸钠的含量及其有关物质丹参酮Ⅰ磺酸钠及丹参酮ⅡA的HPLC测定方法。方法:色谱柱为RestekC18(4.6mm×200mm,5μm);流动相为A相(0.02mol/L磷酸氢二钠缓冲溶液,用磷酸调pH为7.0)-B相(甲醇)进行梯度洗脱(B相起始比例为50%,10min内上升到70%,保持5min,30minB相占95%);流速为1mL/min;检测波长为271nm。结果:被测定峰与其他峰可达到基线分离,丹参酮ⅡA磺酸钠、丹参酮Ⅰ磺酸钠及丹参酮ⅡA的线性范围分别为19.98~119.88μg/mL(r=0.9999),0.202~1.212μg/mL(r=0.9999)及0.202~1.212μg/mL(r=0.9998);平均回收率分别为99.8%,99.6%,99.7%;RSD分别为2.2%,2.0%,2.3%(n=9)。结论:该法简便、准确、分离效果好,适用于该制剂的质量控制及有关物质研究。 Aim : To establish the HPLC method for determination of tanshinone Ⅱ A sulfonate and its related substances (tanshinone Ⅰ sulfonate and tanshinone Ⅱ A)in sulfotanshinone sodium injection. Methods: Restek C18 column(4.6 mm × 200 mm, 5 μm)was used with a mobile phase of A(0.02 mol/L dibasic sodium phosphate, adjusted to pH 7.0)- B(methanol) ,with a linear gradient from 50% to 70% of B phase mixed with A phase in 10 min, retained for 5 min, and the proportion of B phase reached 95 % in 30 min. The flowing rate was 1 mL/min. The detection wavelength was set at 271 nm. Results: A good resolution with baseline separation was obtained. The linear ranges of tanshinone 11 A sulfonate, tanshinone Ⅰ sulfonate and tanshinone ⅡA were 19.98 - 119.88 μg/mL( r = 0.999 9),0.202 - 1.212 μg/ mL(r = 0.999 9)and 0.202- 1.212 μg/mL( r = 0.999 8), respectively. The average recoveries were 99.8%, 99.6 % and 99.7 % with RSDs of 2.2 %, 2.0 % and 2.3 % ( n = 9), respectively. Conclusion: The method is simple, accurate, selective, and reliable for quality control and determination of related substances of sulfotanshinone sodium injection.
出处 《中国药科大学学报》 CAS CSCD 北大核心 2007年第1期47-50,共4页 Journal of China Pharmaceutical University
关键词 注射用丹参酮ⅡA磺酸钠 含量测定 有关物质 HPLC sulfotanshinone sodium Ⅱ A for injection determination of content related substances HPLC
  • 相关文献

参考文献4

  • 1钱名望 杨保津 等.丹参有效成分的研究[J].化学学报,1978,36(3):199-205.
  • 2郑虎占(Zheng HZ),董泽宏(Dong ZH),佘靖(She J).中药现代研究与应用[M].第2卷,北京:学苑出版社,1997:1 093-1 193.
  • 3国家药典委员会.WS-10001-(HD-0923)-2002.国家药品标准(试行):丹参酮ⅡA磺酸钠[S].
  • 4国家药典委员会.WS-10001-(HD-1014)-2002.国家药品标准:丹参酮ⅡA磺酸钠注射液[S].

共引文献14

同被引文献111

引证文献9

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部